Clinical trial
Impact of a Strategy Based on the PCR Testing System on Appropriate and Targeted Antimicrobial Treatment in Immunocompromised Patients With Suspected Ventilator-associated Pneumonia or Hospital-acquired Pneumonia Requiring Mechanical Ventilation : a Randomized Controlled Unblinded Trial
NCT05405491 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of a Strategy Based on the PCR Testing System on Appropriate and Targeted Antimicrobial Treatment in Immunocompromised Patients With Suspected Ventilator-associated Pneumonia or Hospital-acquired Pneumonia Requiring Mechanical Ventilation : a Randomized Controlled Unblinded Trial
- Lead sponsor
- University Hospital, Lille
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 28, 2023
- Completion date
- March 31, 2028
- Enrollment
- 31 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immunodeficiency, pneumonia, hospital-acquired, pneumonia, ventilator-associated